Canadian clinical stage drug development company, Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF), has entered an investigator-initiated clinical...
Privately owned Empyrean Neuroscience, Inc. has launched with a $22 million Series A financing and a genetic engineering platform to advance a pipeline...
Privately-owned psychedelic medicine company Beckley Psytech Limited is buying Eleusis Therapeutics Limited in an all-stock transaction. By acquiring Eleusis,...
Psychedelic medicines company Beckley Psytech has reached an agreement to acquire its rival Eleusis Therapeutics, in alignment with The post Consolidation...
The article Psychedelics and Religious Liberty in the United States was originally published on Microdose. As we all grapple with the ongoing pandemic,...
This month, Alberta, Canada joined the likes of Oregon and (maybe) Colorado in defying federal law to bring much-needed psychedelic treatment to their...
MindMed saw several management changes over the last nine months. The post MindMed Mess Results in Stock Price Roller Coaster appeared first on Green Market...
The article Microdose Announces Algernon Pharmaceuticals as Wonderland 2022 Headline Sponsor was originally published on Microdose. The leader in the...
Albert Labs International Corp. (CSE: ABRT | FSE: VB50), a pharmaceutical drug development company focussed on gaining regulatory approval for active...
Psychedelics and death are two subjects not often discussed within our society. However, these two have the potential to be extremely correlated, as experts...